Characteristics and application of body fluid metabolic profile in patients with kidney stones based on surface-enhanced Raman spectroscopy
10.3969/j.issn.1009-8291.2024.05.012
- VernacularTitle:基于表面增强拉曼光谱的肾结石患者体液代谢谱特点及应用价值
- Author:
Li OUYANG
1
;
Qingjiang XU
;
Xiang WU
;
Juqiang LIN
;
Qianyu LIN
;
Bifang XU
Author Information
1. 福建省立医院泌尿外科,福建福州 350013
- Keywords:
kidney stone;
surface-enhanced Raman spectroscopy;
body fluid;
metabolic testing;
blood;
urine
- From:
Journal of Modern Urology
2024;29(5):440-444
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the characteristics of body fluid metabolic profile in patients with kidney stones based on surface-enhanced Raman spectroscopy,and to explore its application value and provide a reference for the screening of patients with kidney stones.Methods A total of 25 patients with kidney stones and 25 healthy controls were involved.Urine and blood samples were collected,whose spectra were measured with surface-enhanced Raman spectroscopy.The mean and difference spectra were plotted with origin software.The normalized data were processed with principal component analysis combined with linear discriminant analysis(PCA-LDA).Finally,the performance of the PCA-LDA method was evaluated with the receiver operating characteristic(ROC)curve.Results The levels of phosphatidylinositol,phenylalanine,palmitic acid/fatty acids,etc.in the urine of patients with kidney stones are higher than those in healthy controls,while the levels of components such as uracil and glycogen are lower.The content of methyl bands in the plasma of patients with kidney stones is higher than that of healthy controls,while the contents of glycogen,phosphatidylinositol,protein-tyrosine,phenylalanine,palmitic acid/fatty acid,hydroxyproline/tyrosine,and lipids are lower than those of healthy controls.Conclusion Surface-enhanced Raman spectroscopy can identify the changes in various metabolites in patients with kidney stones,and the combination of PCA-LDA and ROC analysis is helpful for the screening of patients.
